FDA pushes back PDUFA for Bavarian's smallpox vaccine

Bavarian Nordic said FDA extended by three months its review of a BLA for its smallpox vaccine, MVA-BN. The new PDUFA date is in September.

Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) said the agency needs more time "due the amount of data submitted during the review phase."...